News | August 03, 2025
Sandoz to acquire Just–Evotec Biologics facility for $300 million
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
It is intended for contrast enhancement in MRI scans
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
A triple-action Formula for comprehensive respiratory relief
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
Subscribe To Our Newsletter & Stay Updated
